The Latest
Image
Our understanding of breast cancer has evolved significantly since it was first documented nearly 5,000 years ago. Explore some of the many milestones in the history of breast cancer research and treatment.
People have known about breast cancer for centuries—maybe longer—with mentions of it dating as far back as ancient Greece and Egypt.1 As our knowledge of cancer has expanded over time, so has our approach to diagnosing and treating it.
Image
Rare cancers include a wide range of cancer types, from unusual subsets of common cancers to cancers in places they don’t normally appear. Here are 8 different rare cancers you may not know about.
Though individual rare cancers affect small numbers of patients per year, they collectively make up a sizeable portion of cancer diagnoses.
Image
While a single rare cancer might affect a small number of patients, rare cancers—as a whole—actually make up about 1 out of every 4 new cancer diagnoses and an estimated 30 percent of all cancer deaths every year.1 Here’s what you need to know about rare cancers and how you can help conquer them.
It’s one of the most persistent and challenging realities of cancer research: Rare cancers—at an individual level—affect fewer people than more common cancers and, as a result, often receive less
Image
ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2025 Quality Care Symposium Merit Awards.
These distinguished awards recognize first authors on top-ranking abstracts selected for presentation at the ASCO Quality Care Symposium on October 10–11, 2025, in Chicago, IL. Each of the following 42 oncology professionals are recognized for their respective field and research advancements within the cancer care community:
Image
With cancer research funding facing critical shortfalls, the competition for grants gets tougher every day. Don’t let these avoidable grant writing mistakes stand between your great idea and the funding you need to make it a reality.
Written by: Kavita Bhalla, PHD
Director, Scientific Review
Image
These are challenging times for early-career oncology researchers and—by extension—the patients and families who need the treatments and cures those researchers dedicate their careers to pursuing. With grants disappearing and federal research funding in short supply, junior investigators are often among the hardest hit.
During this year’s ASCO Annual Meeting, Conquer Cancer had the chance to sit down with a range of young investigators to discuss the state of oncology research funding and the impact on the newest and future generations of oncology researchers.
Sign Up For Our Newsletter
Keep up-to-date with Conquer Cancer: Join our online community to receive updates on how our researchers are making groundbreaking discoveries and what you can do to help.
For PR Professionals
Media Contact:
Email: mediateam@asco.org